Developer docs
API playgroundTry for free, no card

Search company profiles

NuraLogix Corporation

Full company profile

uuid0003wxt

Namestring
NuraLogix Corporation
Legal namestring
NuraLogix Corporation
Websiteurl
nuralogix.ai
Company typeenum
Private
Founded yearint
2015
Descriptiontext

NuraLogix Corporation is a Toronto-based Affective AI company that has built a patented contactless health-measurement platform around its Transdermal Optical Imaging (TOI) technology. Using a standard video camera and a 30-second facial scan, TOI extracts facial blood-flow information and runs it through NuraLogix's cloud-based DeepAffex engine, which applies deep learning and signal processing to predict more than 100 physiological and psychological metrics, including FDA-cleared pulse rate and breathing rate, contactless blood pressure, cardiovascular risk (up to 20 years), digital biomarkers (hypertension, diabetes, fatty liver), mental health indices, BMI, sleep quality, and a vitality/longevity score. The system is delivered as the consumer Anura app, an SDK for third-party platforms, white-label Anura Enterprise deployments, an Anura Telehealth module, a browser-based Web Measurement Service, and hardware form factors (Anura MagicMirror and the $899 Longevity Mirror).

The company serves four primary verticals — insurance, corporate wellness, telehealth, and preventive health apps — and monetizes through a mix of SDK and platform licensing, enterprise white-label and telehealth subscriptions, an API/Web Measurement Service, and direct-to-consumer hardware sales. The free Anura app functions as a top-of-funnel product-led growth asset, while a dedicated regional sales motion (North America, EMEA, APAC, plus a Hangzhou WOFE for China) closes enterprise integrations with insurance carriers, healthcare providers, retail groups, and OEMs. Validation rests on a 1,328-adult clinical study showing ~95% blood pressure accuracy versus a cuff-based monitor and on peer-reviewed publications across AHA, Springer Nature, Scientific Reports, and Frontiers journals.

NuraLogix's defensibility is anchored in a 10+ US-patent portfolio (including US 10,376,192 covering contactless blood pressure determination and US 10,117,588 for camera-based heart rate tracking), FDA 510(k) clearance for the Anura Mobile Core SDK (K263258, June 2026), ISO 13485:2016 and MDSAP certifications (June 2025), HIPAA and GDPR compliance, and a regulatory and scientific bench that includes a former FDA CDRH Director and an emeritus CSO who is a Tier 1 Canada Research Chair. As of 2021 the company had raised over $20M in cumulative funding, employed ~60 staff, and operated with named integration partners including Noom, NTT Data, Sanitas, FWD Group, Hyundai Department Store Group, Nestlé, MyFiziq, and Alula Technologies.

Short descriptiontext

NuraLogix Corporation is a Toronto-based Affective AI company that uses patented Transdermal Optical Imaging (TOI) to extract health metrics — including FDA-cleared pulse and breathing rate, contactless blood pressure, and 20-year cardiovascular risk — from a 30-second facial video, delivered via the Anura app, SDK, telehealth, white-label enterprise, and consumer hardware.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contactless health monitoring, affective AI platform, vital sign measurement, telehealth software, medical device software
Industry3 codes
1Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
CodeHLACAPAIPrimaryYes
2Facial Recognition & Biometrics
CodeHDAAAEACPrimaryNo
3Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
CodeHLAHACALPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Contactless Health Monitoring Software
GTM motion6 records

Each record includes

Type, Description, Source

Revenue model6 records
1SDK Licensing
TypeLicensing Royalties
Description

Software Development Kit licensing for mobile (Android, iOS) and desktop (Windows, Linux, MacOS) platforms, enabling third-party integration of AI-powered health measurement technology into existing applications and devices.

nuralogix.ai
2Enterprise White-Label Solutions
TypeSubscription Recurring
Description

Anura Enterprise platform allowing brands to deliver comprehensive health insights under their own brand, powered by NuraLogix technology with customization options for seamless integration.

nuralogix.ai
3Telehealth Platform Licensing
TypeSubscription Recurring
Description

Anura Telehealth platform licensing for healthcare providers enabling real-time vital sign assessment during video consultations.

nuralogix.ai
4Longevity Mirror Hardware Sales
TypeHardware Sales
Description

Sale of Longevity Mirror device - a tabletop smart mirror priced at $899 that assesses health metrics from facial blood flow analysis for consumer wellness monitoring.

athletechnews.com
5Technology Integration Partnerships
TypeLicensing Royalties
Description

Licensing technology to partners like Noom for integration into their platforms, such as Noom's AI Face Scan feature powered by NuraLogix technology.

globenewswire.com
6B2B API/Web Measurement Service
TypeSubscription Recurring
Description

Anura Web Measurement Service (WMS) providing API access to health measurement capabilities for web-based integrations.

nuralogix.ai
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain, Infrastructure
Pricing details3 tiers
1Longevity Mirror Device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$899 - smart mirror device that scans biomarkers to generate longevity scores using facial blood flow analysis

morningbrew.com
2Anura Consumer App
ModelFreemiumBilling cadenceMonthly
Notes

Free app available on iOS and Android app stores with core health measurement features; some advanced features may require premium subscription

athletechnews.com
3Enterprise/SDK Solutions
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing for Anura Enterprise white-label solutions, SDK licensing, and Telehealth platform - not publicly disclosed

nuralogix.ai
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 8 records shown
1Anura®
Description

Primary consumer health monitoring app using AI and facial analysis to measure vital signs and health metrics via smartphone camera

nuralogix.ai
+7 more records
Core offering1 text field

NuraLogix develops and licenses the DeepAffex Affective AI platform, which uses patented Transdermal Optical Imaging (TOI) technology to derive vital signs and health-risk indicators from a 30-second facial video captured on any standard camera. The company sells this capability through the Anura consumer and enterprise app, Anura Telehealth for video consultations, the Anura Web Measurement Service, a cross-platform Software Development Kit, and two hardware devices (Anura MagicMirror and Longevity Mirror). The offering is FDA 510(k) cleared for contactless Pulse Rate and Breathing Rate measurement and is targeted at insurance, healthcare, telehealth, corporate wellness, OEM, and consumer use cases.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 95% blood pressure measurement accuracy compared to traditional cuff-based monitor in study of 1,328 adults
+4 more records
Product overview1 text field

NuraLogix offers a platform-plus-modules architecture centered on its DeepAffex® cloud-based Affective AI engine. The core product is the Anura® app, which delivers FDA-cleared contactless vital sign measurements via smartphone camera in 30 seconds. This platform is extended through multiple modules: Anura® Enterprise (white-label deployment), Anura® Telehealth (video consultation integration), and Anura® Web Measurement Service (browser-based access). Hardware products include the Anura® MagicMirror™ smart mirror and the Longevity Mirror™ ($899 longevity assessment device). The Software Development Kit (SDK) enables third-party integration across mobile (Android/iOS) and desktop (Windows/Linux/MacOS) platforms. The technology is built on proprietary Transdermal Optical Imaging (TOI™) that extracts facial blood flow information from standard video cameras to predict over 100 health and wellness insights including cardiovascular risk, diabetes risk, and physiological age.

Product and service7 records
1Anura
CategoryConsumer Health Monitoring App
Description

Mobile and web application that uses a smartphone, tablet, laptop, or kiosk camera to measure vital signs and over 100 health and wellness insights via facial blood flow analysis in 30 seconds; FDA-cleared for contactless pulse rate and breathing rate measurement.

2Anura Enterprise
CategoryEnterprise White-Label Health Platform
Description

White-label solution that enables partners to deliver comprehensive health insights under their own brand using NuraLogix's DeepAffex technology, ready to scale and fast to implement.

3Anura Telehealth
CategoryTelehealth Integration Platform
Description

Platform enabling real-time health insights during video consultation sessions, helping healthcare providers assess vital signs early and deliver more informed, connected, and proactive care during telehealth appointments.

4Anura MagicMirror
CategorySmart Mirror Health Hardware
Description

World's first smart MagicMirror that analyzes facial blood flow to reveal health insights and condition likelihood assessments without wearables or contact, using a mirror-like device.

5Longevity Mirror
CategoryConsumer Wellness Hardware
Description

Home wellness device that uses AI and facial analysis to predict users' future health risks up to 20 years ahead; captures facial videos for 30 seconds to generate wellness indicators and personalized health recommendations; priced at $899.

6Anura Web Measurement Service (WMS)
CategoryWeb-Based Health Measurement Service
Description

Web-based vital sign measurement service enabling health assessments through web browsers and PC cameras, providing API access to health measurement capabilities for web-based integrations.

7DeepAffex Software Development Kit (SDK)
CategoryDeveloper SDK for Health AI Integration
Description

SDK that enables integration of AI-powered health measurement technology into existing mobile apps, web platforms, consumer electronics, and home appliances; supports Android, iOS, Windows, Linux, and MacOS with automatic product updates.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-20
Description

NuraLogix partnered with Noom to launch AI Face Scan feature, enabling Noom users to access accessible, real-time health screening through a simple smartphone selfie. Face Scan uses remote photoplethysmography to estimate biological age, vital signs, and metabolic health indicators in 30 seconds.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-04-24
Description

Nestlé and Hyundai Department Store Group deployed Anura MagicMirror in Korea, bringing AI healthcare innovation to Korean consumers through mirror-based health insights when face is projected on the device for 30 seconds.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-04-24
Description

Partnered with Nestlé to deploy Anura MagicMirror at Hyundai Department Store Group locations in Korea, analyzing measured information and blood pressure in about 10 seconds.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-06-06
Description

Alula Technologies, a global leader in advanced technology solutions for insurance, employee benefits, and healthcare, integrated NuraLogix's quick, non-invasive health measurements into their digital platforms.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-01-25
Description

Telepass and Neocogita (Italian neuroscience and wellbeing company) signed agreement for distribution of Anura in Italy to all Telepass customers.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2022-08-11
Description

NuraLogix partnered with 5-HT, a digital hub connecting innovative startups with successful global health players and champions.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-08-08
Description

FWD Group introduced omne app for changing the way people feel about insurance, integrating Anura contactless health and wellness measurement technology.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-02-17
Description

NTT Data began providing Vitals Measurement Service on commercial basis from January 2022 as a new function of its cloud-based health management solution Health Data Bank.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2020-10-08
Description

Sanitas (second largest medical insurance company in Spain, founded 1954) launched BluaU app with Anura technology, allowing users to take vital sign measurements with a 30-second video selfie, connected to Sanitas network of 3,000+ healthcare professionals across 35 specialties.

10MyFiziq
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-08-24
Description

Partnership to develop CompleteScan - world's first total health screen from a mobile phone combining NuraLogix TOI technology with MyFiziq's dimensioning technology, providing blood pressure, stress levels, heart rate, HRV, respiratory rates, emotion, body fat, and disease risk assessments.

nuralogix.ai
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Largest independent telehealth platform in the U.S., a logical distribution/partner channel for Anura Telehealth as well as a potential competitor for integrated virtual-care vitals.

TypeBroad incumbent
Description

Global incumbent in blood pressure and vital-sign monitoring devices, including connected/IFTTT blood-pressure cuffs; comparable as an established channel for vital-sign workflows that NuraLogix targets via contactless alternative.

TypeDirect peer
Description

Israel-based company offering contactless health-vitals measurement from facial video on smartphones, laptops and tablets — same core product category and target use cases (insurance wellness checks, telehealth) as NuraLogix.

TypeBroad incumbent
Description

FDA-cleared ECG and remote cardiac-monitoring platform sold into consumer and clinical workflows; comparable because it competes for the same cardiology/insurance and telehealth vitals budget with a clinical regulatory lead in cardiac measurement.

TypeEmerging player
Description

Applies AI to video/voice for emotion and physiological inference; overlaps with NuraLogix's Affective-AI thesis and could expand into health-vitals models, making it an emerging adjacent player in expressive-computing applied to health.

TypeBroad incumbent
Description

Owns a consumer health SDK and Galaxy Watch biometrics stack used across millions of devices; a comparable broad platform incumbent with on-device vitals and potential to layer similar AI-driven insights.

TypeEmerging player
Description

AI symptom-assessment and digital-health navigation platform sold into insurers, providers and telehealth — comparable as an emerging AI-health workflow seller that competes for the same enterprise integration budgets.

TypeDirect peer
Description

Connected-health device maker (smart scales, watches, blood pressure monitors) targeting consumer wellness and remote patient monitoring; comparable because both bridge consumer hardware with cloud health-insights subscription services.

TypeBroad incumbent
Description

Provides consumer health/wellness platforms (Fitbit devices and Google Health AI) with heart-rate, sleep and respiratory features; comparable broad incumbent for consumer health insights and wellness data aggregation.

TypeBroad incumbent
Description

Bundles heart-rate, ECG, blood-oxygen and emerging sensor-driven vitals into a default consumer platform; comparable as the platform-level incumbent whose camera/sensor stack can absorb rPPG-style capabilities over time.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NuraLogix Corporation

Contactless Health Monitoring Softwarenuralogix.ai

NuraLogix Corporation is a Toronto-based Affective AI company that uses patented Transdermal Optical Imaging (TOI) to extract health metrics — including FDA-cleared pulse and breathing rate, contactless blood pressure, and 20-year cardiovascular risk — from a 30-second facial video, delivered via the Anura app, SDK, telehealth, white-label enterprise, and consumer hardware.

What NuraLogix Corporation does

NuraLogix Corporation is a Toronto-based Affective AI company that has built a patented contactless health-measurement platform around its Transdermal Optical Imaging (TOI) technology. Using a standard video camera and a 30-second facial scan, TOI extracts facial blood-flow information and runs it through NuraLogix's cloud-based DeepAffex engine, which applies deep learning and signal processing to predict more than 100 physiological and psychological metrics, including FDA-cleared pulse rate and breathing rate, contactless blood pressure, cardiovascular risk (up to 20 years), digital biomarkers (hypertension, diabetes, fatty liver), mental health indices, BMI, sleep quality, and a vitality/longevity score. The system is delivered as the consumer Anura app, an SDK for third-party platforms, white-label Anura Enterprise deployments, an Anura Telehealth module, a browser-based Web Measurement Service, and hardware form factors (Anura MagicMirror and the $899 Longevity Mirror).

The company serves four primary verticals — insurance, corporate wellness, telehealth, and preventive health apps — and monetizes through a mix of SDK and platform licensing, enterprise white-label and telehealth subscriptions, an API/Web Measurement Service, and direct-to-consumer hardware sales. The free Anura app functions as a top-of-funnel product-led growth asset, while a dedicated regional sales motion (North America, EMEA, APAC, plus a Hangzhou WOFE for China) closes enterprise integrations with insurance carriers, healthcare providers, retail groups, and OEMs. Validation rests on a 1,328-adult clinical study showing ~95% blood pressure accuracy versus a cuff-based monitor and on peer-reviewed publications across AHA, Springer Nature, Scientific Reports, and Frontiers journals.

NuraLogix's defensibility is anchored in a 10+ US-patent portfolio (including US 10,376,192 covering contactless blood pressure determination and US 10,117,588 for camera-based heart rate tracking), FDA 510(k) clearance for the Anura Mobile Core SDK (K263258, June 2026), ISO 13485:2016 and MDSAP certifications (June 2025), HIPAA and GDPR compliance, and a regulatory and scientific bench that includes a former FDA CDRH Director and an emeritus CSO who is a Tier 1 Canada Research Chair. As of 2021 the company had raised over $20M in cumulative funding, employed ~60 staff, and operated with named integration partners including Noom, NTT Data, Sanitas, FWD Group, Hyundai Department Store Group, Nestlé, MyFiziq, and Alula Technologies.

NuraLogix Corporation firmographics

Firmographics
Name
NuraLogix Corporation
Legal name
NuraLogix Corporation
Website
https://nuralogix.ai
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
NuraLogix Corporation is a Toronto-based Affective AI company that uses patented Transdermal Optical Imaging (TOI) to extract health metrics — including FDA-cleared pulse and breathing rate, contactless blood pressure, and 20-year cardiovascular risk — from a 30-second facial video, delivered via the Anura app, SDK, telehealth, white-label enterprise, and consumer hardware.
Ownership category
akta.pro rank

NuraLogix Corporation industry classification

Industry
Product category
Contactless Health Monitoring Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
akta.pro secondary industries
Facial Recognition & Biometrics (HDAAAEAC), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

Keywords

  • Contactless health monitoring
  • Affective AI platform
  • Vital sign measurement
  • Telehealth software
  • Medical device software

Where NuraLogix Corporation is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices5 records

Markets served

NuraLogix Corporation business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain, Infrastructure

Revenue model

  1. SDK Licensing: Software Development Kit licensing for mobile (Android, iOS) and desktop (Windows, Linux, MacOS) platforms, enabling third-party integration of AI-powered health measurement technology into existing applications and devices.
  2. Enterprise White-Label Solutions: Anura Enterprise platform allowing brands to deliver comprehensive health insights under their own brand, powered by NuraLogix technology with customization options for seamless integration.
  3. Telehealth Platform Licensing: Anura Telehealth platform licensing for healthcare providers enabling real-time vital sign assessment during video consultations.
  4. Longevity Mirror Hardware Sales: Sale of Longevity Mirror device - a tabletop smart mirror priced at $899 that assesses health metrics from facial blood flow analysis for consumer wellness monitoring.
  5. Technology Integration Partnerships: Licensing technology to partners like Noom for integration into their platforms, such as Noom's AI Face Scan feature powered by NuraLogix technology.
  6. B2B API/Web Measurement Service: Anura Web Measurement Service (WMS) providing API access to health measurement capabilities for web-based integrations.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goLongevity Mirror Device
FreemiumMonthlyAnura Consumer App
SubscriptionAnnualEnterprise/SDK Solutions

Go-to-market motion6 records

Distribution channels6 records

Marketing channels6 records

NuraLogix Corporation product offering

Product offering

Core offering

NuraLogix develops and licenses the DeepAffex Affective AI platform, which uses patented Transdermal Optical Imaging (TOI) technology to derive vital signs and health-risk indicators from a 30-second facial video captured on any standard camera. The company sells this capability through the Anura consumer and enterprise app, Anura Telehealth for video consultations, the Anura Web Measurement Service, a cross-platform Software Development Kit, and two hardware devices (Anura MagicMirror and Longevity Mirror). The offering is FDA 510(k) cleared for contactless Pulse Rate and Breathing Rate measurement and is targeted at insurance, healthcare, telehealth, corporate wellness, OEM, and consumer use cases.

Product overview

NuraLogix offers a platform-plus-modules architecture centered on its DeepAffex® cloud-based Affective AI engine. The core product is the Anura® app, which delivers FDA-cleared contactless vital sign measurements via smartphone camera in 30 seconds. This platform is extended through multiple modules: Anura® Enterprise (white-label deployment), Anura® Telehealth (video consultation integration), and Anura® Web Measurement Service (browser-based access). Hardware products include the Anura® MagicMirror™ smart mirror and the Longevity Mirror™ ($899 longevity assessment device). The Software Development Kit (SDK) enables third-party integration across mobile (Android/iOS) and desktop (Windows/Linux/MacOS) platforms. The technology is built on proprietary Transdermal Optical Imaging (TOI™) that extracts facial blood flow information from standard video cameras to predict over 100 health and wellness insights including cardiovascular risk, diabetes risk, and physiological age.

Differentiator

Problem solved

Functional benefit

Brands

  • Anura®: Primary consumer health monitoring app using AI and facial analysis to measure vital signs and health metrics via smartphone camera
  • DeepAffex®
  • Anura® MagicMirror™
  • Anura® Telehealth
  • Anura® Enterprise
  • Longevity Mirror™
  • Transdermal Optical Imaging (TOI™)
  • Affective AI™

Products and services

  • Anura Mobile and web application that uses a smartphone, tablet, laptop, or kiosk camera to measure vital signs and over 100 health and wellness insights via facial blood flow analysis in 30 seconds; FDA-cleared for contactless pulse rate and breathing rate measurement.
  • Anura Enterprise White-label solution that enables partners to deliver comprehensive health insights under their own brand using NuraLogix's DeepAffex technology, ready to scale and fast to implement.
  • Anura Telehealth Platform enabling real-time health insights during video consultation sessions, helping healthcare providers assess vital signs early and deliver more informed, connected, and proactive care during telehealth appointments.
  • Anura MagicMirror World's first smart MagicMirror that analyzes facial blood flow to reveal health insights and condition likelihood assessments without wearables or contact, using a mirror-like device.
  • Longevity Mirror Home wellness device that uses AI and facial analysis to predict users' future health risks up to 20 years ahead; captures facial videos for 30 seconds to generate wellness indicators and personalized health recommendations; priced at $899.
  • Anura Web Measurement Service (WMS) Web-based vital sign measurement service enabling health assessments through web browsers and PC cameras, providing API access to health measurement capabilities for web-based integrations.
  • DeepAffex Software Development Kit (SDK) SDK that enables integration of AI-powered health measurement technology into existing mobile apps, web platforms, consumer electronics, and home appliances; supports Android, iOS, Windows, Linux, and MacOS with automatic product updates.

Quantifiable outcome

  • 95% blood pressure measurement accuracy compared to traditional cuff-based monitor in study of 1,328 adults
  • +4 more outcomes

Companies that use NuraLogix Corporation

Customer profile

Named customers8 records

Segments6 records

Ideal customer profiles4 records

NuraLogix Corporation technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature7 records

NuraLogix Corporation partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • NoomcoreTechnology or Integration · 20 October 2025NuraLogix partnered with Noom to launch AI Face Scan feature, enabling Noom users to access accessible, real-time health screening through a simple smartphone selfie. Face Scan uses remote photoplethysmography to estimate biological age, vital signs, and metabolic health indicators in 30 seconds.
  • NestlécoreChannel Partner/ Reseller/ Distributor · 24 April 2025Nestlé and Hyundai Department Store Group deployed Anura MagicMirror in Korea, bringing AI healthcare innovation to Korean consumers through mirror-based health insights when face is projected on the device for 30 seconds.
  • Hyundai Department Store GroupcoreChannel Partner/ Reseller/ Distributor · 24 April 2025Partnered with Nestlé to deploy Anura MagicMirror at Hyundai Department Store Group locations in Korea, analyzing measured information and blood pressure in about 10 seconds.
  • Alula TechnologiescoreTechnology or Integration · 6 June 2024Alula Technologies, a global leader in advanced technology solutions for insurance, employee benefits, and healthcare, integrated NuraLogix's quick, non-invasive health measurements into their digital platforms.
  • Telepass and NeocogitaminorChannel Partner/ Reseller/ Distributor · 25 January 2023Telepass and Neocogita (Italian neuroscience and wellbeing company) signed agreement for distribution of Anura in Italy to all Telepass customers.
  • 5-HT Digital Innovation HubminorGTM or Marketing Partner · 11 August 2022NuraLogix partnered with 5-HT, a digital hub connecting innovative startups with successful global health players and champions.
  • FWD GroupcoreTechnology or Integration · 8 August 2022FWD Group introduced omne app for changing the way people feel about insurance, integrating Anura contactless health and wellness measurement technology.
  • NTT DatacoreTechnology or Integration · 17 February 2022NTT Data began providing Vitals Measurement Service on commercial basis from January 2022 as a new function of its cloud-based health management solution Health Data Bank.
  • SanitascoreTechnology or Integration · 8 October 2020Sanitas (second largest medical insurance company in Spain, founded 1954) launched BluaU app with Anura technology, allowing users to take vital sign measurements with a 30-second video selfie, connected to Sanitas network of 3,000+ healthcare professionals across 35 specialties.
  • MyFiziqcoreStrategic or Co-development Partner · 24 August 2020Partnership to develop CompleteScan - world's first total health screen from a mobile phone combining NuraLogix TOI technology with MyFiziq's dimensioning technology, providing blood pressure, stress levels, heart rate, HRV, respiratory rates, emotion, body fat, and disease risk assessments.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

NuraLogix Corporation competitors and assessment

Company assessment

Others

  • Teladoc Health: Largest independent telehealth platform in the U.S., a logical distribution/partner channel for Anura Telehealth as well as a potential competitor for integrated virtual-care vitals.

Broad incumbents

  • Omron Healthcare: Global incumbent in blood pressure and vital-sign monitoring devices, including connected/IFTTT blood-pressure cuffs; comparable as an established channel for vital-sign workflows that NuraLogix targets via contactless alternative.
  • AliveCor (KardiaMobile): FDA-cleared ECG and remote cardiac-monitoring platform sold into consumer and clinical workflows; comparable because it competes for the same cardiology/insurance and telehealth vitals budget with a clinical regulatory lead in cardiac measurement.
  • Samsung Health: Owns a consumer health SDK and Galaxy Watch biometrics stack used across millions of devices; a comparable broad platform incumbent with on-device vitals and potential to layer similar AI-driven insights.
  • Google Fit / Fitbit: Provides consumer health/wellness platforms (Fitbit devices and Google Health AI) with heart-rate, sleep and respiratory features; comparable broad incumbent for consumer health insights and wellness data aggregation.
  • Apple (Apple Watch / Health): Bundles heart-rate, ECG, blood-oxygen and emerging sensor-driven vitals into a default consumer platform; comparable as the platform-level incumbent whose camera/sensor stack can absorb rPPG-style capabilities over time.

Direct peers

  • Binah.ai: Israel-based company offering contactless health-vitals measurement from facial video on smartphones, laptops and tablets — same core product category and target use cases (insurance wellness checks, telehealth) as NuraLogix.
  • Withings: Connected-health device maker (smart scales, watches, blood pressure monitors) targeting consumer wellness and remote patient monitoring; comparable because both bridge consumer hardware with cloud health-insights subscription services.

Emerging players

  • Hume AI: Applies AI to video/voice for emotion and physiological inference; overlaps with NuraLogix's Affective-AI thesis and could expand into health-vitals models, making it an emerging adjacent player in expressive-computing applied to health.
  • Ada Health: AI symptom-assessment and digital-health navigation platform sold into insurers, providers and telehealth — comparable as an emerging AI-health workflow seller that competes for the same enterprise integration budgets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

NuraLogix Corporation social profiles

Digital presence

NuraLogix Corporation compliance and trust

Trust signal

Compliance6 records

NuraLogix Corporation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NuraLogix Corporation leadership team

Management profile

Number of profiles

Profiles16 records

NuraLogix Corporation subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

NuraLogix Corporation funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NuraLogix Corporation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NuraLogix Corporation

What does NuraLogix Corporation do?

NuraLogix develops and licenses the DeepAffex Affective AI platform, which uses patented Transdermal Optical Imaging (TOI) technology to derive vital signs and health-risk indicators from a 30-second facial video captured on any standard camera. The company sells this capability through the Anura consumer and enterprise app, Anura Telehealth for video consultations, the Anura Web Measurement Service, a cross-platform Software Development Kit, and two hardware devices (Anura MagicMirror and Longevity Mirror). The offering is FDA 510(k) cleared for contactless Pulse Rate and Breathing Rate measurement and is targeted at insurance, healthcare, telehealth, corporate wellness, OEM, and consumer use cases.

Is NuraLogix Corporation a public or private company?

NuraLogix Corporation is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NuraLogix Corporation founded?

NuraLogix Corporation was founded in 2015. It employs 51 to 100 people.

Where is NuraLogix Corporation based?

NuraLogix Corporation is headquartered in Toronto, Canada, in the North America region.

How does NuraLogix Corporation make money?

Six revenue lines are on record. SDK Licensing is the primary driver. The others are enterprise White-Label Solutions, telehealth Platform Licensing, longevity Mirror Hardware Sales, technology Integration Partnerships and B2B API/Web Measurement Service.

Who are NuraLogix Corporation's main competitors?

Teladoc Health is listed as an others. Broad incumbents are Omron Healthcare, AliveCor (KardiaMobile), Samsung Health, Google Fit / Fitbit and Apple (Apple Watch / Health). Direct peers are Binah.ai and Withings. Emerging players are Hume AI and Ada Health.

Does NuraLogix Corporation have an API?

Yes. DeepAffex Software Development Kit (SDK) enables integration into existing platforms or development of custom software applications. Supports Mobile (Android and iOS), Desktop (Windows, Linux, MacOS) platforms. Product updates are automatically installed for access to recent features. Provides flexibility to customize user experience for seamless integration into customer journeys. Developer documentation is at nuralogix.ai/get-in-touch.

What industry is NuraLogix Corporation in?

NuraLogix Corporation's product category is Contactless Health Monitoring Software. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HDAAAEAC, Facial Recognition & Biometrics. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Med-Tech InsightsNuraLogix Anura Mobile Core SDK receives FDA clearance for contactless measurementNuraLogix received FDA 510(k) clearance for its Anura Mobile Core SDK, enabling contactless measurement of pulse and respiration rates in adults. The clearance covers the SDK's use of Transdermal Optical Imaging (TOI) technology, which analyzes facial blood-flow signals via a standard camera. The company says the clearance supports integration into digital health and telehealth workflows.Mpo-magFDA Clears NuraLogix’s Anura Mobile Core SDK for Heart, Respiration Rate MeasurementNuraLogix received FDA 510(k) clearance for its Anura Mobile Core SDK, which measures pulse and respiration rates in adults using contactless Transdermal Optical Imaging. The clearance allows integration into digital health and telehealth workflows, with measurements taking about 30 seconds. The technology underpins NuraLogix's broader Anura platform.Gadget FlowCES 2026 gadgets for women worth talking aboutCES 2026 showcased health gadgets for women, including the Withings Body Scan 2, NuraLogix Longevity Mirror, Mira Ultra4, Vivoo FlowPad, and L'Oréal LED Face Mask. Prices range from $5 to $899, with features like hormone monitoring and longevity assessments. The author notes these devices address underfunded women's health topics.openPR.comEmotion Artificial Intelligence Market CAGR 48% Growth Outlook by IBM, Microsoft, Eyesight Technologies, Affectiva, NuraLogix, gestigon GmbH, Crowd Emotion, Beyond VerbalThe Emotion AI market is projected to grow at a 48% CAGR from 2025 to 2032, driven by demand for customer experience and mental health monitoring. Key players include IBM, Microsoft, Affectiva, and NuraLogix, with applications in healthcare, marketing, and automotive. Challenges include privacy regulations and ethical concerns.Scripps NewsA mirror that can check your vitals and more health tech at CES 2024Several companies unveiled new health technology devices at CES 2024 in Las Vegas, including Withings' BeamO vital monitor and NuraLogix's Anura MagicMirror. These gadgets utilize advanced sensors and AI to track various health metrics such as heart rate, blood pressure, and respiratory patterns for consumers and medical facilities.Mpo-magCES 2024: ‘Magic’ Mirror Can Conduct Physical and Mental Health AssessmentsNuraLogix unveiled its first hardware product, the Anura MagicMirror, at CES 2024 in Las Vegas, a smart mirror that uses Transdermal Optical Imaging technology to analyze facial blood flow and measure over 100 health parameters including vitals, metabolic health risks, and mental health assessments in a 30-second scan. The device, which received a CES 2024 Innovation Award Honoree recognition for Digital Health, is designed for industry partners including retailers, gyms, schools, corporations, and healthcare facilities to conduct contactless physical and mental health assessments. The MagicMirror builds on NuraLogix's existing DeepAffex AI platform and follows the November 2023 launch of Anura Telehealth.PR NewswireNew contactless health monitoring technology Anura™ enables mobile carriers and handset developers to integrate digital health solutionNuraLogix, a Toronto-based company founded in 2015, showcased its Anura contactless health monitoring platform at MWC 2023 in Barcelona, demonstrating how smartphone video cameras can measure over 30 health parameters including blood pressure, heart rate, and chronic disease risk assessments in just 30 seconds. The technology uses patented Transdermal Optical Imaging and was developed using data from more than 40,000 patients with multiple conditions, with claims of clinical accuracy validated through 10 peer-reviewed publications and 13 U.S. patents.PR NewswireNew contactless health monitoring technology Anura™ enables mobile carriers and handset developers to integrate digital health solutionNuraLogix, a company founded in 2015, is showcasing its Anura contactless health monitoring platform at MWC 2023 in Barcelona, demonstrating technology that can measure over 30 health parameters including blood pressure, blood glucose risk, and pre-diabetes risk in just 30 seconds using only a smartphone video camera. The platform uses the company's patented Transdermal Optical Imaging technology, developed with data from more than 40,000 patients and validated through 10 peer-reviewed publications. NuraLogix claims its blood pressure measurement achieves an accuracy standard deviation of less than 8mmHg, with existing customers including NTT Data, Bupa Group, AIA, and FWD building bespoke health programs using Anura capabilities.PR NewswireCorrection - Health in Transportation Releases New Smartphone Face-Scanning Application Aimed at Uncovering Potentially Serious Health Concerns in Professional DriversHealth in Transportation released CDL Health Scanner, a smartphone application using NuraLogix's Transdermal Optical Imaging technology to scan drivers' faces and analyze vital signs for conditions like hypertension and type-2 diabetes. The corrected press release clarifies that the technology is for investigational use only, does not diagnose or predict medical conditions, and is not a substitute for professional medical judgment. The app aims to help address the transportation industry's driver shortage by alerting drivers to health concerns before they result in medical disqualification.PR NewswireNuraLogix Researchers Announce the Capability to Assess Type 2 Diabetes and Blood Biomarker Health Issues Using Any Video-Enabled DeviceNuraLogix researchers announced the expansion of their Anura™ platform to include metabolic and blood biomarker health risk assessments for chronic conditions including Type 2 diabetes, hypertension, and hypertriglyceridemia. The platform uses Transdermal Optical Imaging technology to analyze facial blood flow patterns from a 30-second video selfie, representing the first video-based contactless health monitoring solution capable of such assessments. The new capabilities were unveiled at the HLTH conference in Las Vegas and built on data from more than 40,000 patients.